RIGL - Rigel Pharmaceuticals
IEX Last Trade
13.45
-0.100 -0.743%
Share volume: 100,019
Last Updated: Fri 30 Aug 2024 09:59:53 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$13.55
-0.10
-0.74%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-02 | 2022-11-03 | 2023-03-07 | 2023-05-02 | 2023-08-01 | 2023-11-07 | 2024-03-05 | 2024-05-07 | |
| Total revenue | 29.819 M | 22.410 M | 51.278 M | 26.070 M | 26.886 M | 28.134 M | 35.792 M | 29.534 M | |
| Cost of revenue | 1.036 M | 250.000 K | 342.000 K | 977.000 K | 1.075 M | 1.268 M | 3.790 M | 2.025 M | |
| Gross profit | 28.783 M | 22.160 M | 50.936 M | 25.093 M | 25.811 M | 26.866 M | 32.002 M | 27.509 M | |
| -23.01% | 129.86% | -50.74% | 2.86% | 4.09% | 19.12% | -14.04% | |||
| Operating expenses | 41.748 M | 40.563 M | 47.537 M | 37.818 M | 31.078 M | 31.331 M | 30.036 M | 34.475 M | |
| Selling general and admin | 26.981 M | 25.897 M | 32.172 M | 27.729 M | 26.306 M | 24.856 M | 26.850 M | 28.449 M | |
| Research and development | 14.767 M | 14.666 M | 15.365 M | 10.089 M | 4.772 M | 6.475 M | 3.186 M | 6.026 M | |
| Total expenses | 42.784 M | 40.813 M | 47.879 M | 38.795 M | 32.153 M | 32.599 M | 33.826 M | 36.500 M | |
| -4.61% | 17.31% | -18.97% | -17.12% | 1.39% | 3.76% | 7.91% | |||
| Operating income | -12.965 M | -18.403 M | 3.399 M | -12.725 M | -5.267 M | -4.465 M | 1.966 M | -6.966 M | |
| Ebit | -12.965 M | -18.403 M | 3.399 M | -12.725 M | -5.267 M | -4.465 M | 1.966 M | -6.966 M | |
| Pretax income | -13.492 M | -19.037 M | 1.401 M | -13.536 M | -6.600 M | -5.692 M | 737.000 K | -8.247 M | |
| 41.10% | -107.36% | -1,066.17% | -51.24% | -13.76% | -112.95% | -1,219.00% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -13.492 M | -19.037 M | 1.401 M | -13.536 M | -6.600 M | -5.692 M | 737.000 K | -8.247 M | |
| -41.10% | 107.36% | -1,066.17% | 51.24% | 13.76% | 112.95% | -1,219.00% | |||
| Net income | -13.492 M | -19.037 M | 1.401 M | -13.536 M | -6.600 M | -5.692 M | 737.000 K | -8.247 M | |
| -41.10% | 107.36% | -1,066.17% | 51.24% | 13.76% | 112.95% | -1,219.00% |